Bristol-Myers Squibb Co (NYSE:BMY)

60.92
Delayed Data
As of Feb 27
 -0.54 / -0.88%
Today’s Change
46.30
Today|||52-Week Range
64.44
+3.20%
Year-to-Date
Which Cancer Immunotherapy Will Be the Most Successful?
Feb 28 / MotleyFool.com
Morning Buzz: Rigel Pharmaceuticals (RIGL), Celldex (CLDX), Tower Semiconductor (TSEM...
Feb 23 / Investing Channel
Bristol Myers Reports Data Supporting Clinical Development Of BMS-955176
Feb 26 / Benzinga
The $10 Billion Reason That This Tiny Biotech Stock Could Soar
Feb 22 / MotleyFool.com
Bristol-Myers Squibb Launches Phase III Trial Of HIV Drug
Feb 25 / Benzinga
Why Momenta Pharmaceuticals, Inc. Jumped Higher Today
Feb 19 / MotleyFool.com
The 3 Biggest Disappointments This Earnings Season
Feb 25 / MotleyFool.com
Seattle Genetics' SEA-CD40 Enters Phase I for Solid Tumors - Analyst Blog
Feb 18 / Zacks.com
Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog
Feb 24 / Zacks.com
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Feb 18 / MotleyFool.com
Stock Market News for February 24, 2015 - Market News
Feb 24 / Zacks.com
Waiting for the Momenta to Regain
Feb 17 / MotleyFool.com
Will Celldex Therapeutics (CLDX) Disappoint This Earnings? - Analyst Blog
Feb 23 / Zacks.com
Merck KGaA to Gain Full Marketing Rights to Erbitux in Japan - Analyst Blog
Feb 16 / Zacks.com
Why Shares of Rigel Pharmaceuticals Inc. Exploded Today
Feb 23 / MotleyFool.com
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Feb 16 / MotleyFool.com
Unusual 11 Mid-Day Movers 2/23: (BIOC) (RIGL) (TSEM) Higher; ((AXN) (FULL) (SPPI) Low...
Feb 23 / Investing Channel
The Small-Cap Biotech Stock You Should Be Watching
Feb 15 / MotleyFool.com
Energy stocks retreat after crude declines
Feb 23 / FT.com
Forget Traditional Chemotherapy! Could 3D Vaccines Eventually Cure Cancer?
Feb 15 / MotleyFool.com
Bristol-Myers Commits Up to $1.25 Billion to Add Flexus Cancer Therapies
Feb 23 / TheStreet.com
Big pharmaceuticals groups faces biosimilars challenge
Feb 02 / FT.com
Morning Market Gainers
Feb 23 / Benzinga
US profitability: the rich list
Jan 30 / FT.com
Pre-Open Stock Movers 02/23: (RIGL) (DGLY) (VRX) (PPO) Higher; (SPPI) (CYBR) (BA) Low...
Feb 23 / Investing Channel
 

To view my watchlist

Not a member yet?

Sign up now for a free account